Skip to content

Dental Caries Management by Risk Assessment: Identification and Treatment of Risk Factors Among (IDF) Personnel

Dental Caries Management by Risk Assessment: Identification and Treatment of Risk Factors Among Israeli Defence Force (IDF) Personnel

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01142440
Acronym
CAMBRA
Enrollment
400
Registered
2010-06-11
Start date
2010-06-30
Completion date
2012-03-31
Last updated
2011-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Caries

Brief summary

Our study is designed as an interventional prospective longitudinal study which examines the Israeli defense force personnel. The population of our study is composed out of the IDF personnel which will be randomly be subdivided into 2 different groups - one will be noted as the intervention group and the other will function as a control group. Each participant will be monitored for a period of 18 months.

Detailed description

On the intervention group, which includes a couple of hundreds participants, a thorough caries management by risk assessment plan will be conducted. The risk assessment will include the following criteria: * Saliva check * Plaque control * Plaque acidity * Diet - Frequency of carbohydrate intake * Previous caries experience and present carious activity * Others (prosthetic/orthodontic appliances, systemic diseases etc.) After obtaining the data the patients will be categorized into 1 of 3 distinct risk level - low, medium, high. Each category will be treated according to a tailored treatment protocol: * Dietary instructions * Oral hygiene instructions * Antibacterial therapy * Fluorides * Restoration * Follow ups The control group will be treated according to standard protocol of treatment in the IDF dental clinics, which is based on removal the cavitated lesions, and lacks any reference to caries as a multifactorial infectious disease. We assume that personalized treatment of the disease, based on identifying risk factors will lower the number of patients with active disease.

Interventions

BEHAVIORALbehavioral intervention

* Dietary instructions * Oral hygiene instructions: GC plaque indicator kit * Antibacterial therapy: medident sol. one week a month, for 6 months * Fluorides: VOCO Profluorid varnish, once every 3 month * Restoration * Follow ups

Sponsors

Medical Corps, Israel Defense Force
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Informed consent

Exclusion criteria

* Pregnancy * Available for 18 month follow-up

Design outcomes

Primary

MeasureTime frame
Improvement in one of the risk factors (such as eating habits, saliva, plaque control, fluorides).6 months

Secondary

MeasureTime frame
Progression of the disease in 30% of patients in the control group in comparison to only 15% in the intervention group.18 months

Countries

Israel

Contacts

Primary ContactEinav Hirschhorn, DMD
ariel_hirschhorn_77@hotmail.com972-57-8182218

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026